Aditi Kadakia, MS, is affiliated with Sunovion Pharmaceuticals Inc. in Marlborough, Massachusetts. Kadakia has authored articles focusing on the economic and fiscal burdens associated with schizophrenia and schizoaffective disorders. Contributions include analyses of the lifetime and national economic impacts of schizophrenia within government and healthcare frameworks. Collaborators frequently include G. Rhys Williams, Annika Anderson, Carole Dembek, Jessica R. Marden, and Mark P. Connolly.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
